Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2016 (2016), Article ID 1393089, 9 pages
http://dx.doi.org/10.1155/2016/1393089
Research Article

Methylation Status of Alu and LINE-1 Interspersed Repetitive Sequences in Behcet’s Disease Patients

1Center of Excellence in Immunology and Immune-Mediated Diseases, Department of Microbiology, Faculty of Medicine, Chulalongkorn University, Bangkok 10330, Thailand
2Ankara Education and Research Hospital, Altindag, 06340 Ankara, Turkey
3Gazi University Faculty of Medicine, Yenimahalle, 06560 Ankara, Turkey

Received 6 January 2016; Revised 17 February 2016; Accepted 6 March 2016

Academic Editor: Yves Renaudineau

Copyright © 2016 Şahru Yüksel et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. H. Behçet, “Über rezidivierende, aphthöse durch ein virus verursachte geschwure am mund, am auge und an den genitalen,” Dermatologische Wochenschrift, vol. 105, pp. 1152–1157, 1937. View at Google Scholar
  2. N. Düzgün, E. Ayaşlioğlu, H. Tutkak, and O. T. Aydintuğ, “Cytokine inhibitors: soluble tumor necrosis factor receptor 1 and interleukin-1 receptor antagonist in Behçet's disease,” Rheumatology International, vol. 25, no. 1, pp. 1–5, 2005. View at Publisher · View at Google Scholar · View at Scopus
  3. J.-L. Mege, N. Dilsen, V. Sanguedolce et al., “Overproduction of monocyte derived tumor necrosis factor α, interleukin (IL) 6, IL-8 and increased neutrophil superoxide generation in Behcet's disease. A comparative study with familial Mediterranean fever and healthy subjects,” Journal of Rheumatology, vol. 20, no. 9, pp. 1544–1549, 1993. View at Google Scholar · View at Scopus
  4. E. Eksioglu-Demiralp, H. Direskeneli, A. Kibaroglu, S. Yavuz, T. Ergun, and T. Akoglu, “Neutrophil activation in Behçet's disease,” Clinical and Experimental Rheumatology, vol. 19, supplement 5, pp. S19–S24, 2001. View at Google Scholar · View at Scopus
  5. A. Gül, “Behçet's disease as an autoinflammatory disorder,” Current Drug Targets: Inflammation and Allergy, vol. 4, no. 1, pp. 81–83, 2005. View at Publisher · View at Google Scholar · View at Scopus
  6. P. Atagunduz, T. Ergun, and H. Direskeneli, “MEFV mutations are increased in Behçet's disease (BD) and are associated with vascular involvement,” Clinical and Experimental Rheumatology, vol. 21, supplement 30, no. 4, pp. S35–S37, 2003. View at Google Scholar · View at Scopus
  7. H. Yazici, Y. Tuzun, H. Pazarli et al., “Influence of age of onset and patient's sex on the prevalence and severity of manifestations of Behcet's syndrome,” Annals of the Rheumatic Diseases, vol. 43, no. 6, pp. 783–789, 1984. View at Google Scholar
  8. U. Tursen, A. Gurler, and A. Boyvat, “Evaluation of clinical findings according to sex in 2313 Turkish patients with Behçet's disease,” International Journal of Dermatology, vol. 42, no. 5, pp. 346–351, 2003. View at Publisher · View at Google Scholar · View at Scopus
  9. S. Yurdakul and H. Yazici, “Behçet's syndrome,” Best Practice and Research: Clinical Rheumatology, vol. 22, no. 5, pp. 793–809, 2008. View at Publisher · View at Google Scholar · View at Scopus
  10. H. Direskeneli, “Autoimmunity vs autoinflammation in Behcet's disease: do we oversimplify a complex disorder?” Rheumatology, vol. 45, no. 12, pp. 1461–1465, 2006. View at Publisher · View at Google Scholar · View at Scopus
  11. I. Koné-Paut, I. Geisler, B. Wechsler et al., “Familial aggregation in Behcet's disease: high frequency in siblings and parents of pediatric probands,” The Journal of Pediatrics, vol. 135, no. 1, pp. 89–93, 1999. View at Publisher · View at Google Scholar · View at Scopus
  12. A. Gül and S. Ohno, “Genetics of Behçet's disease,” in Behçet's Syndrome, Y. Yazıcı and H. Yazıcı, Eds., pp. 265–276, Springer, New York, NY, USA, 2010. View at Google Scholar
  13. D. H. Verity, J. E. Marr, S. Ohno, G. R. Wallace, and M. R. Stanford, “Behcet's disease, the Silk Road and HLA-B51: historical and geographical perspectives,” Tissue Antigens, vol. 54, no. 3, pp. 213–220, 1999. View at Publisher · View at Google Scholar · View at Scopus
  14. A. Gül, “Behçet's disease: an update on the pathogenesis,” Clinical and Experimental Rheumatology, vol. 19, no. 5, supplement 24, pp. S6–S12, 2001. View at Google Scholar
  15. E. F. Remmers, F. Cosan, Y. Kirino et al., “Genome-wide association study identifies variants in the MHC class I, IL10, and IL23R-IL12RB2 regions associated with Behçet's disease,” Nature Genetics, vol. 42, no. 8, pp. 698–702, 2010. View at Publisher · View at Google Scholar · View at Scopus
  16. N. Mizuki, A. Meguro, M. Ota et al., “Genome-wide association studies identify IL23R-IL12RB2 and IL10 as Behçet's disease susceptibility loci,” Nature Genetics, vol. 42, no. 8, pp. 703–706, 2010. View at Publisher · View at Google Scholar · View at Scopus
  17. Y. Kirino, G. Bertsias, Y. Ishigatsubo et al., “Genome-wide association analysis identifies new susceptibility loci for Behçet's disease and epistasis between HLA-B51 and ERAP1,” Nature Genetics, vol. 45, no. 2, pp. 202–207, 2013. View at Publisher · View at Google Scholar · View at Scopus
  18. J. K. Ahn, H.-S. Cha, J. Lee, C. H. Jeon, and E.-M. Koh, “Correlation of DEFA1 gene copy number variation with intestinal involvement in Behcet's disease,” Journal of Korean Medical Science, vol. 27, no. 1, pp. 107–109, 2012. View at Publisher · View at Google Scholar · View at Scopus
  19. H. Yu, L. Luo, L. Wu et al., “FAS gene copy numbers are associated with susceptibility to Behçet disease and VKH syndrome in Han Chinese,” Human Mutation, vol. 36, no. 11, pp. 1064–1069, 2015. View at Publisher · View at Google Scholar · View at Scopus
  20. M. Zheng, H. Yu, L. Zhang et al., “Association of ATG5 Gene polymorphisms with Behcet's disease and ATG10 gene polymorphisms with VKH syndrome in a Chinese Han population,” Investigative Opthalmology & Visual Science, vol. 56, no. 13, pp. 8280–8287, 2015. View at Publisher · View at Google Scholar
  21. J. Qi, S. Hou, Q. Zhang et al., “A functional variant of pre-miRNA-196a2 confers risk for Behcet's disease but not for Vogt-Koyanagi-Harada syndrome or AAU in ankylosing spondylitis,” Human Genetics, vol. 132, no. 12, pp. 1395–1404, 2013. View at Publisher · View at Google Scholar · View at Scopus
  22. H. Yu, Y. Liu, L. Bai, A. Kijlstra, and P. Yang, “Predisposition to Behçet's disease and VKH syndrome by genetic variants of miR-182,” Journal of Molecular Medicine, vol. 92, no. 9, pp. 961–967, 2014. View at Publisher · View at Google Scholar · View at Scopus
  23. Q. Zhou, S. Hou, L. Liang et al., “MicroRNA-146a and Ets-1 gene polymorphisms in ocular Behçet's disease and Vogt-Koyanagi-Harada syndrome,” Annals of the Rheumatic Diseases, vol. 73, no. 1, pp. 170–176, 2014. View at Publisher · View at Google Scholar · View at Scopus
  24. T. Hughes, F. Ture-Ozdemir, F. Alibaz-Oner, P. Coit, H. Direskeneli, and A. H. Sawalha, “Epigenome-wide scan identifies a treatment-responsive pattern of altered dna methylation among cytoskeletal remodeling genes in monocytes and CD4+ T cells from patients with behçet's disease,” Arthritis and Rheumatology, vol. 66, no. 6, pp. 1648–1658, 2014. View at Publisher · View at Google Scholar · View at Scopus
  25. S. Levy, G. Sutton, P. C. Ng et al., “The diploid genome sequence of an individual human,” PLoS Biology, vol. 5, no. 10, article e254, 2007. View at Publisher · View at Google Scholar · View at Scopus
  26. N. Bannert and R. Kurth, “Retroelements and the human genome: new perspectives on an old relation,” Proceedings of the National Academy of Sciences of the United States of America, vol. 101, supplement 2, pp. 14572–14579, 2004. View at Publisher · View at Google Scholar · View at Scopus
  27. Z. Zhang and R. Zhang, “Epigenetics in autoimmune diseases: pathogenesis and prospects for therapy,” Autoimmunity Reviews, vol. 14, no. 10, pp. 854–863, 2015. View at Publisher · View at Google Scholar · View at Scopus
  28. J. Nakkuntod, Y. Avihingsanon, A. Mutirangura, and N. Hirankarn, “Hypomethylation of LINE-1 but not Alu in lymphocyte subsets of systemic lupus erythematosus patients,” Clinica Chimica Acta, vol. 412, no. 15-16, pp. 1457–1461, 2011. View at Publisher · View at Google Scholar · View at Scopus
  29. P. Sukapan, P. Promnarate, Y. Avihingsanon, A. Mutirangura, and N. Hirankarn, “Types of DNA methylation status of the interspersed repetitive sequences for LINE-1, Alu, HERV-E and HERV-K in the neutrophils from systemic lupus erythematosus patients and healthy controls,” Journal of Human Genetics, vol. 59, no. 4, pp. 178–188, 2014. View at Publisher · View at Google Scholar · View at Scopus
  30. S. Yooyongsatit, K. Ruchusatsawat, N. Noppakun, N. Hirankarn, A. Mutirangura, and J. Wongpiyabovorn, “Patterns and functional roles of LINE-1 and Alu methylation in the keratinocyte from patients with psoriasis vulgaris,” Journal of Human Genetics, vol. 60, no. 7, pp. 349–355, 2015. View at Publisher · View at Google Scholar · View at Scopus
  31. M. Ali, D. J. Veale, R. J. Reece et al., “Overexpression of transcripts containing LINE-1 in the synovia of patients with rheumatoid arthritis,” Annals of the Rheumatic Diseases, vol. 62, no. 7, pp. 663–666, 2003. View at Publisher · View at Google Scholar · View at Scopus
  32. E. Karouzakis, R. E. Gay, B. A. Michel, S. Gay, and M. Neidhart, “DNA hypomethylation in rheumatoid arthritis synovial fibroblasts,” Arthritis and Rheumatism, vol. 60, no. 12, pp. 3613–3622, 2009. View at Publisher · View at Google Scholar · View at Scopus
  33. I. R. Miousse and I. Koturbash, “The fine LINE: methylation drawing the cancer landscape,” BioMed Research International, vol. 2015, Article ID 131547, 8 pages, 2015. View at Publisher · View at Google Scholar · View at Scopus
  34. Y. Luo, X. Lu, and H. Xie, “Dynamic Alu methylation during normal development, aging, and tumorigenesis,” BioMed Research International, vol. 2014, Article ID 784706, 12 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  35. S. Garaud, C. Le Dantec, S. Jousse-Joulin et al., “IL-6 modulates CD5 expression in B cells from patients with lupus by regulating DNA methylation,” The Journal of Immunology, vol. 182, no. 9, pp. 5623–5632, 2009. View at Publisher · View at Google Scholar · View at Scopus
  36. S. Garaud, C. Le Dantec, C. Berthou, P. M. Lydyard, P. Youinou, and Y. Renaudineau, “Selection of the alternative exon 1 from the cd5 gene down-regulates membrane level of the protein in B lymphocytes,” Journal of Immunology, vol. 181, no. 3, pp. 2010–2018, 2008. View at Publisher · View at Google Scholar · View at Scopus
  37. J. Sicat, N. Sutkowski, and B. T. Huber, “Expression of human endogenous retrovirus HERV-K18 superantigen is elevated in juvenile rheumatoid arthritis,” Journal of Rheumatology, vol. 32, no. 9, pp. 1821–1831, 2005. View at Google Scholar · View at Scopus
  38. M. Magnusson, S. Magnusson, H. Vallin, L. Rönnblom, and G. V. Alm, “Importance of CpG dinucleotides in activation of natural IFN-α-producing cells by a lupus-related oligodeoxynucleotide,” Scandinavian Journal of Immunology, vol. 54, no. 6, pp. 543–550, 2001. View at Publisher · View at Google Scholar · View at Scopus
  39. M. K. Crow, “Long interspersed nuclear elements (LINE-1): potential triggers of systemic autoimmune disease,” Autoimmunity, vol. 43, no. 1, pp. 7–16, 2010. View at Publisher · View at Google Scholar · View at Scopus
  40. P. Jintaridth and A. Mutirangura, “Distinctive patterns of age-dependent hypomethylation in interspersed repetitive sequences,” Physiological Genomics, vol. 41, no. 2, pp. 194–200, 2010. View at Publisher · View at Google Scholar · View at Scopus
  41. V. Bollati, J. Schwartz, R. Wright et al., “Decline in genomic DNA methylation through aging in a cohort of elderly subjects,” Mechanisms of Ageing and Development, vol. 130, no. 4, pp. 234–239, 2009. View at Publisher · View at Google Scholar · View at Scopus
  42. Y. Baba, A. Murata, M. Watanabe, and H. Baba, “Clinical implications of the LINE-1 methylation levels in patients with gastrointestinal cancer,” Surgery Today, vol. 44, no. 10, pp. 1807–1816, 2014. View at Publisher · View at Google Scholar · View at Scopus
  43. V. Tarallo, Y. Hirano, B. D. Gelfand et al., “DICER1 loss and Alu RNA induce age-related macular degeneration via the NLRP3 inflammasome and MyD88,” Cell, vol. 149, no. 4, pp. 847–859, 2012. View at Publisher · View at Google Scholar · View at Scopus
  44. B. D. Gelfand, C. B. Wright, Y. Kim et al., “Iron toxicity in the retina requires Alu RNA and the NLRP3 inflammasome,” Cell Reports, vol. 11, no. 11, pp. 1686–1693, 2015. View at Publisher · View at Google Scholar · View at Scopus
  45. S. Yuksel, E. Eren, G. Hatemi et al., “Novel NLRP3/cryopyrin mutations and pro-inflammatory cytokine profiles in Behcet's syndrome patients,” International Immunology, vol. 26, no. 2, pp. 71–81, 2014. View at Publisher · View at Google Scholar